CASE REPORT article
Front. Vet. Sci.
Sec. Veterinary Imaging
Volume 12 - 2025 | doi: 10.3389/fvets.2025.1682168
This article is part of the Research TopicPrecision Diagnosis and Targeted Therapies in Companion Animal OncologyView all articles
Case Report: Palliative Radiotherapy Monitoring Using Computed Tomography and Diffusion-Weighted Magnetic Resonance Imaging in a Cat with Ceruminous Gland Adenocarcinoma
Provisionally accepted- 1College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju-si, Republic of Korea
- 2College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Ceruminous gland adenocarcinoma is the most common malignant tumor of the feline external ear canal. These tumors are often locally invasive and may extend into adjacent musculature and lymph nodes, limiting the feasibility of surgical excision. When surgery is not an option, radiation therapy can provide palliative benefit. Advanced imaging modalities, including computed tomography (CT) and magnetic resonance imaging (MRI), play a crucial role in treatment planning and therapeutic monitoring. Case description A 14-year-old spayed female Persian cat with a confirmed diagnosis of ceruminous gland adenocarcinoma presented with a progressively enlarging mass in the left external ear canal. Due to extensive local invasion into the adjacent parotid and salivary regions, surgical resection was not feasible. The cat was treated with palliative-intent radiation therapy (36 Gy in 6 weekly fractions). Serial CT and MRI, including diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) mapping, were performed on days 0 (radiotherapy completion), 30, 90, and 180 to monitor treatment response. During the initial follow-up period, imaging demonstrated sustained tumor size reduction, symptomatic improvement, and minimal adverse effects. Functional MRI delineated residual lesions more clearly than conventional sequences, supporting its role in post-treatment assessment. However, on day 180, imaging revealed suspected local recurrence and regional lymph node metastases, suggesting disease progression. Despite this, the treatment successfully achieved the intended palliative goals, including temporary tumor control and clinical stabilization. Conclusion This report described a rare case of feline ceruminous gland adenocarcinoma characterized by local invasiveness that precluded surgical resection. Palliative radiotherapy was administered, and sequential imaging using computed tomography and diffusion-weighted magnetic resonance imaging, including ADC mapping, enabled detailed monitoring of the tumor response. Although conventional imaging confirmed size reduction, DWI-MRI better delineated residual lesions, suggesting its complementary role in radiotherapy assessment. This case underscores the value of combining anatomic and functional imaging for evaluating radiotherapy outcomes and guiding clinical decision-making in feline oncology.
Keywords: Ear canal tumor, feline, Palliative radiation therapy, Ceruminous adenocarcinoma, Apparent diffusion coefficient
Received: 08 Aug 2025; Accepted: 14 Oct 2025.
Copyright: © 2025 Kim, KIM, Hong, KIM, Yoon and Choi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jihye Choi, imsono@snu.ac.kr
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.